John Galvin
About John Galvin
John Galvin serves as a Study Coordinator and Principal Investigator at Inotiv in Boulder, Colorado, where he has worked since 2021. He holds an MBA from Colorado State University and has extensive research experience, including publications on the interferon pathway and contributions to Alzheimer's disease research.
Work at Inotiv
John Galvin currently serves as a Study Coordinator and Principal Investigator at Inotiv in Boulder, Colorado. He has been with the company since 2021, contributing to various research initiatives. His role involves coordinating studies and overseeing research projects, leveraging his extensive background in research coordination and technical expertise.
Education and Expertise
John Galvin holds a Master of Business Administration (MBA) from Colorado State University, which he completed from 2016 to 2019. He also earned a Bachelor of Science (BS) and a Master of Science (MS) in Biology from the University of Denver, studying from 2002 to 2006 and 2008 to 2010, respectively. His educational background supports his research capabilities in the field of biology and business management.
Background
Before joining Inotiv, John Galvin worked at Bolder BioPATH, Inc. for seven years, where he held positions as a Research Coordinator and Research Technician. His experience includes developing mouse colonies for studying viral growth and immune responses, as well as motivating undergraduate students in research related to Alzheimer's disease.
Research Contributions
John Galvin has published two papers focusing on the significance of the interferon pathway in virus infection during his tenure at the University of Colorado. He worked under Dr. Kenneth Tyler in the neurology department, contributing to research that enhances understanding of viral interactions with the immune system.
Mentorship and Leadership
In his academic career, John Galvin became a senior member of Dr. Christina Coughlan's lab at the University of Denver, where he served as a graduate research assistant. He played a key role in mentoring undergraduate students, guiding them in designing and executing research questions related to Alzheimer's disease.